As we demonstrated that systemic administration of β‐glucan after mice lung injury significantly decreased the level of hydroxyproline in the lung, we believe β‐glucan could have therapeutic potential against PF in the clinic. The gene discussed is PPIB; the disease is pemphigus foliaceus.